In our first public National Heart, Lung, and Blood Institute (NHLBI) Innovative Clinical Trials Resource (ICTR) webinar, Berry Consultants& ...
Berry Consultants will again have a strong presence at this year’s ASA Biopharmaceutical Section Regulatory-Industry Statistics Worksh ...
Berry Consultants is once again a sponsor for this year's Joint Statistical Meetings (JSM) on July 28 – August 2 in Vancouver, Bri ...
Hierarchical modeling is a powerful tool for making inferences about multiple groups in clinical trials, whether these groups are multiple i ...
Berry Consultants is delighted to announce that FACTS 6.1 is ready for release! Building on FACTS 6, FACTS 6.1 adds two new Dose Escalation ...
This week, we (Melanie Quintana, Roger Lewis, and myself) have an article in JAMA entitled “Bayesian Analysis : Use of Prior Informati ...
Platform trials can efficiently evaluate multiple treatments simultaneously and employ unique statistical analyses to define best therapies. ...
Duke Clinical Research Institute is announcing a public meeting to disseminate and discuss the results of an NIH-funded project (known ...
Berry Consultants is once again a sponsor and will have significant presence at this year's Joint Statistical Meetings (JSM) held o ...
Today, The Clinical Trials Transformation Initiative (CTTI), released recommendations and best practices for the use of Data Monitoring Comm ...